This week's artwork was donated by Jaclyn, a pediatric cancer patient who received treatment at The Children's Hospital of Philadelphia . National Cancer Institute Treatment option overview The myeloproliferative disorders, excluding chronic myelogenous leukemia, are chronic diseases with a variable propensity to convert into acute myelogenous leukemia. Patients with polycythemia vera and essential thrombocythemia have marked increases of red cell and platelet production, respectively.
Treatment is directed at reducing the excessive numbers of blood cells.
Bleeding and thrombosis in the myeloproliferative disorders. PDQ statements exist for a number of topics. Please consult the PDQ Index . This document is also available in a text-only format . The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease.